152 related articles for article (PubMed ID: 30445744)
1. Methylation-Based Classification of Cervical Squamous Cell Carcinoma into Two New Subclasses Differing in Immune-Related Gene Expression.
Li X; Cai Y
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30445744
[TBL] [Abstract][Full Text] [Related]
2. Methylation of RAD51B, XRCC3 and other homologous recombination genes is associated with expression of immune checkpoints and an inflammatory signature in squamous cell carcinoma of the head and neck, lung and cervix.
Rieke DT; Ochsenreither S; Klinghammer K; Seiwert TY; Klauschen F; Tinhofer I; Keilholz U
Oncotarget; 2016 Nov; 7(46):75379-75393. PubMed ID: 27683114
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation data-based molecular subtype classification related to the prognosis of patients with cervical cancer.
Li C; Ke J; Liu J; Su J
J Cell Biochem; 2020 Mar; 121(3):2713-2724. PubMed ID: 31680300
[TBL] [Abstract][Full Text] [Related]
4. A prognostic signature based on immune-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma.
Liu J; Wu Z; Wang Y; Nie S; Sun R; Yang J; Cheng W
Int Immunopharmacol; 2020 Nov; 88():106884. PubMed ID: 32795900
[TBL] [Abstract][Full Text] [Related]
5. Identification of cervical squamous cell carcinoma feature genes and construction of a prognostic model based on immune-related features.
He C; Ren L; Yuan M; Liu M; Liu K; Qian X; Lu J
BMC Womens Health; 2022 Sep; 22(1):365. PubMed ID: 36057587
[TBL] [Abstract][Full Text] [Related]
6. Identification of key classification features of early cervical squamous cell carcinoma.
Wang X; Cao A; Hou Z; Li X; Gao B
Comput Biol Chem; 2021 Aug; 93():107531. PubMed ID: 34217008
[TBL] [Abstract][Full Text] [Related]
7. Constructing a Novel Signature Based on Immune-Related lncRNA to Improve Prognosis Prediction of Cervical Squamous Cell Carcinoma Patients.
Lv X; Liu L; Li P; Yuan Y; Peng M; Jin H; Qin D
Reprod Sci; 2022 Mar; 29(3):800-815. PubMed ID: 35075611
[TBL] [Abstract][Full Text] [Related]
8. HPV-related methylation-based reclassification and risk stratification of cervical cancer.
Yang S; Wu Y; Wang S; Xu P; Deng Y; Wang M; Liu K; Tian T; Zhu Y; Li N; Zhou L; Dai Z; Kang H
Mol Oncol; 2020 Sep; 14(9):2124-2141. PubMed ID: 32408396
[TBL] [Abstract][Full Text] [Related]
9. Immunogenomic Identification for Predicting the Prognosis of Cervical Cancer Patients.
Wang Q; Vattai A; Vilsmaier T; Kaltofen T; Steger A; Mayr D; Mahner S; Jeschke U; Hildegard Heidegger H
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33671013
[TBL] [Abstract][Full Text] [Related]
10. Immune landscape and heterogeneity of cervical squamous cell carcinoma and adenocarcinoma.
Liu B; Xu Y; Hu B; Song X; Lin S; Wang J; Wang L; Chu T; Peng T; Xu M; Ding W; Cao C; Wu P; Li L
Aging (Albany NY); 2024 Jan; 16(1):568-592. PubMed ID: 38206304
[TBL] [Abstract][Full Text] [Related]
11. The differences in immune features and genomic profiling between squamous cell carcinoma and adenocarcinoma - A multi-center study in Chinese patients with uterine cervical cancer.
Li J; Xue X; Zhang Y; Ding F; Wu W; Liu C; Xu Y; Chen H; Ou Q; Shao Y; Li X; Wu F; Wu X
Gynecol Oncol; 2023 Aug; 175():133-141. PubMed ID: 37356314
[TBL] [Abstract][Full Text] [Related]
12. The transcriptome profiles and methylation status revealed the potential cancer-related lncRNAs in patients with cervical cancer.
Yuan LY; Qin X; Li L; Zhou J; Zhou M; Li X; Xu Y; Wang XJ; Xing H
J Cell Physiol; 2019 Jun; 234(6):9756-9763. PubMed ID: 30362566
[TBL] [Abstract][Full Text] [Related]
13. Effect of GLIS1 on the Lymph Node Metastasis of Cervical Squamous Carcinoma Based on Transcriptome Analysis.
Huang J; Zhao Y
Reprod Sci; 2024 May; 31(5):1332-1344. PubMed ID: 38157104
[TBL] [Abstract][Full Text] [Related]
14. Prognostic genes in the tumor microenvironment in cervical squamous cell carcinoma.
Pan XB; Lu Y; Huang JL; Long Y; Yao DS
Aging (Albany NY); 2019 Nov; 11(22):10154-10166. PubMed ID: 31740624
[TBL] [Abstract][Full Text] [Related]
15. Aberrant gene-specific DNA methylation signature analysis in cervical cancer.
Bhat S; Kabekkodu SP; Varghese VK; Chakrabarty S; Mallya SP; Rotti H; Pandey D; Kushtagi P; Satyamoorthy K
Tumour Biol; 2017 Mar; 39(3):1010428317694573. PubMed ID: 28351298
[TBL] [Abstract][Full Text] [Related]
16. Aberrant promoter methylation and silencing of the POU2F3 gene in cervical cancer.
Zhang Z; Huettner PC; Nguyen L; Bidder M; Funk MC; Li J; Rader JS
Oncogene; 2006 Aug; 25(39):5436-45. PubMed ID: 16607278
[TBL] [Abstract][Full Text] [Related]
17. Expression and methylation patterns partition luminal-A breast tumors into distinct prognostic subgroups.
Netanely D; Avraham A; Ben-Baruch A; Evron E; Shamir R
Breast Cancer Res; 2016 Jul; 18(1):74. PubMed ID: 27386846
[TBL] [Abstract][Full Text] [Related]
18. An integrated methylation and gene expression microarray analysis reveals significant prognostic biomarkers in oral squamous cell carcinoma.
Zhao C; Zou H; Zhang J; Wang J; Liu H
Oncol Rep; 2018 Nov; 40(5):2637-2647. PubMed ID: 30226546
[TBL] [Abstract][Full Text] [Related]
19. Methylation of the RASSF1A gene promoter in Uigur women with cervical squamous cell carcinoma.
Pan Z; Li J; Pan X; Chen S; Wang Z; Li F; Qu S; Shao R
Tumori; 2009; 95(1):76-80. PubMed ID: 19366060
[TBL] [Abstract][Full Text] [Related]
20. Comparison of DNA hypermethylation patterns in different types of uterine cancer: cervical squamous cell carcinoma, cervical adenocarcinoma and endometrial adenocarcinoma.
Kang S; Kim JW; Kang GH; Lee S; Park NH; Song YS; Park SY; Kang SB; Lee HP
Int J Cancer; 2006 May; 118(9):2168-71. PubMed ID: 16331610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
